Bosentan in Children With Pulmonary Arterial Hypertension Extension Study (FUTURE 2)

NCT00319020 PHASE3 COMPLETED Results posted

The main objective of the FUTURE 2 study was to assess the long-term safety and tolerability of the pediatric formulation of bosentan in children with idiopathic pulmonary arterial hypertension or familial pulmonary arterial hypertension who completed FUTURE 1 study.

Details

Lead sponsor	Actelion
Phase	PHASE3
Status	COMPLETED
Enrolment	33
Start date	Tue Aug 23 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Oct 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Pulmonary Arterial Hypertension

Interventions

• Bosentan